EverQuote, Inc. $EVER Shares Purchased by Emerald Mutual Fund Advisers Trust

Emerald Mutual Fund Advisers Trust boosted its stake in EverQuote, Inc. (NASDAQ:EVERFree Report) by 14.8% in the 3rd quarter, Holdings Channel reports. The firm owned 416,662 shares of the company’s stock after purchasing an additional 53,695 shares during the period. Emerald Mutual Fund Advisers Trust’s holdings in EverQuote were worth $9,529,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the company. Royal Bank of Canada boosted its position in shares of EverQuote by 1,705.9% during the first quarter. Royal Bank of Canada now owns 65,428 shares of the company’s stock worth $1,713,000 after buying an additional 61,805 shares during the period. Amundi purchased a new position in EverQuote during the 1st quarter valued at about $290,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in EverQuote by 4.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,007 shares of the company’s stock valued at $393,000 after acquiring an additional 624 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in EverQuote by 615.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 339,672 shares of the company’s stock valued at $8,896,000 after acquiring an additional 292,172 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC purchased a new stake in EverQuote during the second quarter worth about $455,000. 91.54% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CAO Jon Ayotte sold 3,639 shares of the business’s stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $26.76, for a total transaction of $97,379.64. Following the completion of the sale, the chief accounting officer owned 49,233 shares in the company, valued at $1,317,475.08. The trade was a 6.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John L. Shields sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $25.73, for a total value of $51,460.00. Following the completion of the transaction, the director directly owned 25,219 shares of the company’s stock, valued at $648,884.87. This trade represents a 7.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 59,507 shares of company stock valued at $1,494,612. 25.52% of the stock is owned by insiders.

EverQuote Trading Up 1.5%

Shares of NASDAQ:EVER opened at $24.45 on Friday. EverQuote, Inc. has a 52 week low of $17.35 and a 52 week high of $30.03. The company’s 50 day moving average is $26.10 and its two-hundred day moving average is $24.34. The company has a market cap of $879.22 million, a PE ratio of 17.10 and a beta of 0.46.

EverQuote (NASDAQ:EVERGet Free Report) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.13. The business had revenue of $173.94 million during the quarter, compared to analysts’ expectations of $166.09 million. EverQuote had a net margin of 8.36% and a return on equity of 38.19%. The company’s revenue for the quarter was up 20.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.31 EPS. As a group, equities research analysts expect that EverQuote, Inc. will post 0.72 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on EVER. Wall Street Zen lowered shares of EverQuote from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 1st. JPMorgan Chase & Co. increased their target price on shares of EverQuote from $30.00 to $32.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Zacks Research upgraded shares of EverQuote from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, November 4th. Needham & Company LLC upped their price objective on EverQuote from $38.00 to $40.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of EverQuote in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, EverQuote has a consensus rating of “Buy” and an average price target of $34.00.

View Our Latest Analysis on EVER

EverQuote Profile

(Free Report)

EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.

The company’s core business centers on a quote-comparison engine for personal auto, home, and health insurance products.

Further Reading

Want to see what other hedge funds are holding EVER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for EverQuote, Inc. (NASDAQ:EVERFree Report).

Institutional Ownership by Quarter for EverQuote (NASDAQ:EVER)

Receive News & Ratings for EverQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EverQuote and related companies with MarketBeat.com's FREE daily email newsletter.